Publications by authors named "Jeffrey Schein"

Claim this Profile
R
Real world analysis of treatment change and response in adults with attention-deficit/hyperactivity disorder (ADHD) alone and with concomitant psychiatric comorbidities: results from an electronic health record database study is the United States.
Christian Liman, Jeffrey Schein, Ashley Wu, Xueyan Huang, Simran Thadani

BMC Psychiatry· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of post-traumatic stress disorder in the United States: a systematic literature review.
Jeffrey Schein, Christy Houle, Annette Urganus, Martin Cloutier, Oscar Patterson-Lomba

Curr Med Res Opin· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of machine learning methodology for the prediction of healthcare resource utilization and healthcare costs in patients with critical limb ischemia-is preventive and personalized approach on the horizon?
Jeffrey S Berger, Lloyd Haskell, Windsor Ting, Fedor Lurie, Shun-Chiao Chang, Jeffrey R Schein

EPMA J· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of clinical outcomes among nonvalvular atrial fibrillation patients treated with rivaroxaban or warfarin, stratified by renal function
.
Matthew R Weir, Lloyd Haskell, Jeffrey S Berger, Veronica Ashton, François Laliberté, Jeffrey Schein

Clin Nephrol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications of stroke and bleeding risk scores and comorbidities on episode-based bundled payments for patients with nonvalvular atrial fibrillation.
Scott Kaatz, Craig I Coleman, Brahim Bookhart, François Laliberté, Winnie W Nelson, Jeffrey Schein

Curr Med Res Opin· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of renal function on ischemic stroke and major bleeding rates in nonvalvular atrial fibrillation patients treated with warfarin or rivaroxaban: a retrospective cohort study using real-world evidence.
Matthew R Weir, Jeffrey S Berger, Veronica Ashton, François Laliberté, Kip Brown, Jeffrey Schein

Curr Med Res Opin· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to Rivaroxaban Compared with Other Oral Anticoagulant Agents Among Patients with Nonvalvular Atrial Fibrillation.
Colleen A McHorney, Veronica Ashton, François Laliberté, Guillaume Germain, Willy Wynant, Jeffrey R Schein

J Manag Care Spec Pharm· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of international normalized ratio values among new warfarin patients with nonvalvular atrial fibrillation.
Winnie W Nelson, Dejan Milentijevic, Li Wang, Onur Baser, C V Damaraju, Jeffrey R Schein

Blood Coagul Fibrinolysis· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Adherence to Rivaroxaban Versus Apixaban Among Patients With Atrial Fibrillation.
Colleen A McHorney, Eric D Peterson, François Laliberté, Guillaume Germain, Winnie W Nelson, Jeffrey Schein

Clin Ther· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of US prescription patterns: Are treatment guidelines for cancer-associated venous thromboembolism being followed?
Alok A Khorana, Daniel Yannicelli, Keith R McCrae, Dejan Milentijevic, Concetta Crivera, Jeffrey R Schein

Thromb Res· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospitalizations and Other Health Care Resource Utilization Among Patients with Deep Vein Thrombosis Treated with Rivaroxaban Versus Low-molecular-weight Heparin and Warfarin in the Outpatient Setting.
Steven Deitelzweig, François Laliberté, Concetta Crivera, Guillaume Germain, Brahim K Bookhart, Jeffrey Schein

Clin Ther· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacy quality alliance measure: adherence to non-warfarin oral anticoagulant medications.
Concetta Crivera, Winnie W Nelson, Brahim Bookhart, Silas Martin, Guillaume Germain, Jeffrey Schein

Curr Med Res Opin· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medication persistence and discontinuation of rivaroxaban and dabigatran etexilate among patients with non-valvular atrial fibrillation.
Winnie W Nelson, Xue Song, Erin Thomson, David M Smith, Craig I Coleman, Jeffrey R Schein

Curr Med Res Opin· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of vital sign measurement timing on Pulmonary Embolism Severity Index (PESI) and simplified PESI 30-day mortality risk determination.
Heather M Rozjabek, Craig I Coleman, Erin R Weeda, W Frank Peacock, Gregory J Fermann, Jeffrey R Schein

Thromb Res· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measure.
Colleen A McHorney, Concetta Crivera, François Laliberté, Winnie W Nelson, Guillaume Germain, Jeffrey Schein

Curr Med Res Opin· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the multivariable In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) prediction rule within an all-payer inpatient administrative claims database.
Craig I Coleman, Christine G Kohn, Concetta Crivera, Jeffrey R Schein, W Frank Peacock

BMJ Open· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Out-of-range international normalized ratio values and healthcare cost among new warfarin patients with non-valvular atrial fibrillation.
Winnie W Nelson, Li Wang, Onur Baser, C V Damaraju, Jeffrey R Schein

J Med Econ· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users.
François Laliberté, Michel Cloutier, Concetta Crivera, Winnie W Nelson, William H Olson, Jeffrey Schein

Adv Ther· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of rivaroxaban versus warfarin on hospitalization days and other health care resource utilization in patients with nonvalvular atrial fibrillation: an observational study from a cohort of matched users.
François Laliberté, Michel Cloutier, Concetta Crivera, Winnie W Nelson, William H Olson, Jeffrey Schein

Clin Ther· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of rivaroxaban versus warfarin on health care costs among nonvalvular atrial fibrillation patients: observations from rivaroxaban users and matched warfarin users.
François Laliberté, Michel Cloutier, Concetta Crivera, Winnie W Nelson, William H Olson, Jeffrey Schein

Adv Ther· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Out-of-range INR values and outcomes among new warfarin patients with non-valvular atrial fibrillation.
Winnie W Nelson, Li Wang, Onur Baser, Chandrasekharrao V Damaraju, Jeffrey R Schein

Int J Clin Pharm· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medication persistence and discontinuation of rivaroxaban versus warfarin among patients with non-valvular atrial fibrillation.
Winnie W Nelson, Xue Song, Craig I Coleman, Erin Thomson, David M Smith, Jeffrey R Schein

Curr Med Res Opin· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients.
François Laliberté, Michel Cloutier, Winnie W Nelson, Craig I Coleman, Dominic Pilon, Jeffrey R Schein

Curr Med Res Opin· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of co-morbidities and patient characteristics on international normalized ratio control over time in patients with nonvalvular atrial fibrillation.
Winnie W Nelson, Jiyoon C Choi, Julie Vanderpoel, Chandrasekharra V Damaraju, Peter Wildgoose, Jeffrey R Schein

Am J Cardiol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and economic outcomes among hospitalized patients with acute coronary syndrome: an analysis of a national representative Medicare population.
Shih-Yin Chen, Concetta Crivera, Michael Stokes, Luke Boulanger, Jeffrey Schein

Clinicoecon Outcomes Res· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis